This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Add to favourites
For Healthcare Professionals
Slenyto (prolonged-release melatonin) Treatment Algorithm

This treatment decision algorithm allows healthcare professionals to personalise titration of Slenyto to optimal dose.

Treatment success is attained by achieving one or more of the following:

  • total sleep time within the recommended range for the subject’s age
  • sleep onset <30 minutes
  • longest sleep episode >6 hours
PRODUCT: Slenyto®

Related Education and Training items